Kenneth GaoSVP, Corporate Development and Strategy at Accro BioscienceSpeaker
Profile
Kenneth Gao serves as Senior Vice President of Corporate Development and Strategy at Accro Bioscience, where he oversees business development, corporate strategy, and strategic financing. Prior to Accropeutics, Kenneth most recently served as Vice President of Corporate Development and Alliance Management at Overland Pharmaceuticals, a fully integrated biopharma company backed by Hillhouse Capital. Before Overland, Kenneth was Senior Director of Corporate Development and Head of China Operations at Assembly Biosciences, a leading infectious disease biotech focused on HBV cure therapies. Kenneth earned an MBA in Health Sector Management from Duke University and a B.S. in Finance from the State University of New York at Buffalo.